In a first step, the expression status of these ten genes was analyzed in the Oncomine database pointing at HES1 as a promising candidate that is clearly reduced in metastatic versus primary MTC tissues (Fig. 2a, right). The gene discussed is HES1; the disease is medullary thyroid gland carcinoma.